Category: Articles

Just as you have a business/sales plan in place ahead of a financial year, having an intellectual property strategy that reflects the longer-term objectives of the company is also crucial. In this context, it...

Alibaba is composed of several core businesses and is often described as a hybrid of Amazon, PayPal and eBay in China. Some of these include: a. Taobao.com         -an e-commerce platform for small...

In most countries, plants and inventions directed to plants or plant products (e.g. seeds) are not eligible for a patent grant despite of widely known commercial uses of new plant varieties in agriculture, horticulture,...

Google recently filed a US patent for embedding tiny microscopic cameras into contact lenses. It is interesting to see how innovative businesses and inventors are exploring unique applications for contact lenses. We will, in...

Swiss giant Novartis has dragged Biocon to Delhi High Court for allegedly infringing patent rights of its diabetes drug “Galvus” and now Biocon cannot manufacture, sell or export vildagliptin until the next hearing. The multinational is seeking an injunction...

Touted to be among “the biggest breakthroughs in medicine in the last 10 years”, Sofosbuvir (brand name Sovaldi) was approved on December 6, 2013 by the U.S. Food and Drug Administration (FDA) as a new treatment...

Indian Patent Office recently published Patent (Amendment) Rules, 2014 and it includes few major updates that anyone applying for patents in India must be aware of. Following are the major ones that will really...

Google’s $3.2 billion acquisition of smart thermostat company, Nest Labs which also is its second biggest ever is certain to fortify company’s place in terms of intellectual property. Google had been weak on patents...

In 2006, the Indian patent office had rejected the patent application for Novartis cancer drug, “Glivec” on grounds that – –    The original molecule imatinib was in public domain before 1995—the cut-off year...